Comparative study on the prevalence of clinically detectable prostate cancer in patients with and without bladder cancer.
D000230:Adenocarcinoma / Q000097:blood / Q000175:diagnosis / Q000453:epidemiology*; D000368:Aged; D014408:Biomarkers, Tumor / Q000097:blood; D002295:Carcinoma, Transitional Cell / Q000453:epidemiology* / Q000601:surgery; D015331:Cohort Studies; D015653:Cystectomy; D006801:Humans; D007564:Japan / Q000453:epidemiology; D008297:Male; D008403:Mass Screening; D008875:Middle Aged; D009363:Neoplasm Proteins / Q000097:blood; D009378:Neoplasms, Multiple Primary / Q000453:epidemiology*; D016609:Neoplasms, Second Primary / Q000453:epidemiology*; D010173:Palpation; D015995:Prevalence; D017430:Prostate-Specific Antigen / Q000097:blood; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000097:blood / Q000175:diagnosis / Q000453:epidemiology*; D012307:Risk Factors; D001749:Urinary Bladder Neoplasms / Q000453:epidemiology* / Q000601:surgery
D014408:Biomarkers, Tumor; D009363:Neoplasm Proteins; D017430:Prostate-Specific Antigen